MedPath

Relapse Rate in an Inflammatory Disease of Breast Treated by Pharmaceutical and Surgical Approaches

Phase 3
Conditions
Idiopathic Granulomatous Mastitis.
Inflammatory disorders of breast
Registration Number
IRCT2013123015999N1
Lead Sponsor
Vice chancellor for research Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
59
Inclusion Criteria

Women who are well documented Idiopathic Granulomatous Mastitis (IGM) patients via pathological finding, IGM patient being not treated
Exclusion criteria: Dissuasion of individuals for treatment procedures.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relapse. Timepoint: Patients were monthly examined for 15 months (from initiation of the intervention to 6 months after cessation of the intervention). Method of measurement: physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath